Ana Lucrecia Woodward

Array ( [id] => 4555281 [patent_doc_number] => 07820820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Method of preparation of azaindole derivatives' [patent_app_type] => utility [patent_app_number] => 12/546108 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7420 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820820.pdf [firstpage_image] =>[orig_patent_app_number] => 12546108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4500943 [patent_doc_number] => 07919494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound' [patent_app_type] => utility [patent_app_number] => 12/543690 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67050 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919494.pdf [firstpage_image] =>[orig_patent_app_number] => 12543690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507958 [patent_doc_number] => 07915261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound' [patent_app_type] => utility [patent_app_number] => 12/543659 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67052 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915261.pdf [firstpage_image] =>[orig_patent_app_number] => 12543659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304189 [patent_doc_number] => 20090298841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/541456 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15282 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298841.pdf [firstpage_image] =>[orig_patent_app_number] => 12541456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374985 [patent_doc_number] => 20090312546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/540452 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52014 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312546.pdf [firstpage_image] =>[orig_patent_app_number] => 12540452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959604 [patent_doc_number] => 20110183991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => '5HT7 RECEPTOR LIGANDS AND COMPOSITIONS COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/063947 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5298 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183991.pdf [firstpage_image] =>[orig_patent_app_number] => 13063947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144780 [patent_doc_number] => 20110130408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PIPERAZIN-1-YL-TRIFLUOROMETHYL-SUBSTITUTED-PYRIDINES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/056287 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15395 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130408.pdf [firstpage_image] =>[orig_patent_app_number] => 13056287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10142170 [patent_doc_number] => 09174969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Indoline scaffold SHP-2 inhibitors and cancer treatment method' [patent_app_type] => utility [patent_app_number] => 13/055113 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 24886 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305941 [patent_doc_number] => 08227473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Oxabicycloheptanes and oxabicycloheptenes, their preparation and use' [patent_app_type] => utility [patent_app_number] => 12/460404 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9076 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12460404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682253 [patent_doc_number] => 20100022555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Novel Derivatives' [patent_app_type] => utility [patent_app_number] => 12/503125 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32809 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022555.pdf [firstpage_image] =>[orig_patent_app_number] => 12503125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144612 [patent_doc_number] => 20110130379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/054265 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17776 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130379.pdf [firstpage_image] =>[orig_patent_app_number] => 13054265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545000 [patent_doc_number] => 20100016282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'NOVEL HETEROCYCLYL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/499120 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47635 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016282.pdf [firstpage_image] =>[orig_patent_app_number] => 12499120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558822 [patent_doc_number] => 20090270399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'NOVEL PYRIDAZINE DERIVATIVES AND MEDICINES CONTAINING THE SAME AS EFFECTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 12/497797 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39104 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270399.pdf [firstpage_image] =>[orig_patent_app_number] => 12497797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026584 [patent_doc_number] => 08536166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Inhibitors of Burton\'s tyrosine kinase' [patent_app_type] => utility [patent_app_number] => 12/459595 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34786 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12459595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375833 [patent_doc_number] => 08680097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Benzothiophene alkanol piperazine derivatives and their use as antidepressant' [patent_app_type] => utility [patent_app_number] => 13/001998 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13044 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13001998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465779 [patent_doc_number] => 20090325979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/492615 [patent_app_country] => US [patent_app_date] => 2009-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19012 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325979.pdf [firstpage_image] =>[orig_patent_app_number] => 12492615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797129 [patent_doc_number] => 08435998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Crystalline form of posaconazole' [patent_app_type] => utility [patent_app_number] => 12/993351 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9463 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374780 [patent_doc_number] => 20090312341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT' [patent_app_type] => utility [patent_app_number] => 12/490884 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25448 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312341.pdf [firstpage_image] =>[orig_patent_app_number] => 12490884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545298 [patent_doc_number] => 20100016297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'ALKYL-SUBSTITUTED 3\' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY' [patent_app_type] => utility [patent_app_number] => 12/488908 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25199 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016297.pdf [firstpage_image] =>[orig_patent_app_number] => 12488908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398407 [patent_doc_number] => 20090318470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => '1-SUBSTITUTED-3-(NAPHTHALEN-1-YLSULFONYL)-5-(PIPERAZIN-1-YL)-1H-INDAZOLE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/487690 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12311 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318470.pdf [firstpage_image] =>[orig_patent_app_number] => 12487690 [rel_patent_id] =>[rel_patent_doc_number] =>)